C WorldWide Group’s Treace Medical Concepts TMCI Stock Holding History

C WorldWide Group’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,000	Closed	-$93K	–	88
2021 Q4	$93K	Hold	5,000	–	–	﹤0.01%	93
2021 Q3	$134K	Hold	5,000	–	–	﹤0.01%	90
2021 Q2	$156K	Buy	+5,000	New	+$159K	﹤0.01%	86

Other funds holding TMCI

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

C WorldWide Group's TMCI Position: Q1 2022 in Review

C WorldWide Group sold out of Treace Medical Concepts (TMCI) in Q1 2022, closing a stake of 5,000 shares — an estimated $93K sold.

C WorldWide Group first reported a position in TMCI in Q2 2021 and held it in 3 quarters. The position peaked at $156K in Q2 2021. 75 funds tracked by Wall St. Rank hold TMCI as of Q1 2022.

C WorldWide Group reported no remaining Treace Medical Concepts position as of Q1 2022 after selling out during the quarter.
C WorldWide Group sold 5,000 Treace Medical Concepts shares in Q1 2022, an estimated $93K.
C WorldWide Group first reported a position in Treace Medical Concepts in Q2 2021 and held it in 3 quarters.
C WorldWide Group's Treace Medical Concepts position peaked at $156K in Q2 2021.
75 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2022.

Based on C WorldWide Group's 13F filing for Q1 2022, filed 4 May 2022.